Latest Stock Split Details
Key information about Neuren Pharmaceuticals Limited's most recent stock split
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Neuren Pharmaceuticals Limited's stock splits
Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
---|---|---|---|---|
2017-11-21 | 1:20 | Yes | $0.01 | N/A |
2012-06-21 | 32:29 | No | $132.41 | $120.00 |
2007-12-26 | 27:25 | No | $1048.72 | $971.03 |
About Neuren Pharmaceuticals Limited
Company overview and industry information
Neuren Pharmaceuticals Limited (NURPF) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.